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Abstract
Purpose: To eliminate CD44, a putative cancer stem cell (CSC) marker,overexpressing  head and neck squamous cell carcinoma (HNSCC) cells by usinghyaluronan-conjugated, dextran-coated super paramagnetic iron oxidenanoparticles (HA-DESPIONs), in conjunction with induced heat produced byexposure to an alternating magnetic field (AMF). Methods: An AMF generator wasconstructed by means of a solenoid coil and an impedance circuit driven by a poweramplifier. A signal generator produced a small sinusoidal signal of 130 kHz that wasthen amplified to 9 A (peak to peak value) to generate an AMF of approximately 10kA/m (12.6 mT) at the center of a coil. The heat generating effect of the AMFgenerator was tested via several kinetic and dose-dependent bulk heatingexperiments by exposing readily available magnetic nanoparticles to AMF. Forelimination of CD44 population, UT-SCC-14 cells were exposed to either targetedHA-DESPIONs or non-targeted DESPIONs at a concentration 200 μg/ml and exposedto AMF for 30 minutes. Cells were processed after 24 hours for flow cytometrybased analysis of apoptosis. Results: Magnetic nanoparticles caused aconcentration-dependent bulk heating effect in response to AMF resulting in asignificant temperature rise. Following the exposure to AMF, non-conjugatedDESPIONs were unable to induce targeted hyperthermia and hence had no effect onCD44 cell death in HNSCC cells. However, there was a significant cell death in theCD44 population treated with HA-DESPIONs and exposed to AMF. This effect wasonly obeserved when the magnetic field was turned on. Conclusion: Bulk heatingexperiments concluded that a simple AMF generator was able to activate magneticnanoparticles and flow cytometry demonstrated that HA- DESPIONs were able tocause apoptosis in UT-SCC-14 cells that express CD44.This may be a promisingstrategy to specifically target cancer stem cells (CSCs) for the treatment of HNSCC.
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1. IntroductionHead and neck squamous cell carcinoma (HNSCC) is themost frequent malignant form of head and neck canceroriginating from the mucosal lining of the upperaerodigestive tract. HNSCC is the sixth most common
cancer worldwide with approximately 5,00,000 newcases each year.1 Despite advances in technologies suchas surgery, radiation therapy and chemotherapy, it stillhas a poor prognosis and survival rates have not
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improved substantially in the last decade.2 Currentlythere is much interest in the existence and activity ofcancer stem cells (CSCs) in HNSCC as a potential reasonwhy conventional therapies fail to eradicate tumors.3CSCs possess intrinsic survival mechanisms that mayprotect them from radiotherapy and chemotherapy.4The major challenges for the recent innovations are tospecifically target CSCs. CD44 is a surface adhesivesingle-chain glycoprotein and a high affinity bindingpartner for hyaluronic acid/hyaluronan (HA)5,6 and hasbeen identified as a putative CSC biomarker in HNSCC4.HA is a naturally occurring, polyanionic, polysaccharideand a major component of the extracellular matrix thatplays a significant role in a variety of cell signalingprocesses such as wound healing, cell differentiation,proliferation, and migration.7 Recent evidence hasstrengthened the potential role of CD44 in HNSCC CSCsand their influence on disease progression andtreatment outcome by investigating the mechanism ofHA-CD44 interaction in the context of cancerprogression and metastasis.8Recently, superparamagnetic iron oxide nanoparticles(SPIONs) have been used extensively for cancer imaging,drug delivery and therapy (including chemotherapy).9,10There are several developing treatment strategies aimedat HNSCC in addition to surgery, chemotherapy andradiation including targeted therapies11, hyperthermiaand thermoablation therapy. In addition to these,ablative or thermotherapy using SPIONS has beeninvestigated for head and neck cancers as an alternative,minimally invasive and inexpensive treatment.11,12 Onepromising thermotherapy strategy is targetedmagnetic-activated hyperthermia. Magnetic hyperther-mia can be achieved by delivering magneticnanoparticles to cancer cells/tissue and creating localheat in the presence of an externally applied alternatingmagnetic field (AMF), which results in thermo-ablationof the cancer cells/tissue.13 The AMF-induced heating ofthese magnetic nanoparticles is through Néel relaxationand /or Brownian motion.14 Magnetic alternatingcurrent-based hyperthermia therapy has beenintroduced in the treatment of head and neck cancer andlung cancer12,15 while magnetic nanoparticle-basednanotherapy has been investigated for the treatment oftumors of the central nervous system16,17. In one recentstudy, induced hyperthermia was achieved for thetreatment of head and neck cancer using a mousexenograft model of a human HNSCC cell line.12 However,it is yet to be determined whether targeted SPIONsfunctionalized with HA exhibit targeted magnetichyperthermia. Targeted magnetic hyperthermia wouldovercome some of the limitations of the currenthyperthermia protocols, including heat induced ablationto the normal surroundings. To address this limitation,we have taken the approach of targeting a ligand specificreceptor (in this case CD44) by usinghyaluronan-conjugated, dextran-coated superparamagnetic iron oxide nanoparticles (HA-DESPIONs).
We have recently demonstrated that HA-DESPIONs werenon-toxic and, although they did not enhance radiationsensitivity, they increased the effect of localhyperthermia.18 Further, these nanoparticles havepreviously been shown to be detectable in tumors andatherosclerotic plaques using static magnetic fields toprovide contrast for magnetic resonance imaging.10,20 Inthis study, HA-DESPIONs with a diameter of 103 nm, inconjunction with induced heat produced by exposure toan AMF, were evaluated for their effects on the viabilityof CD44 expressing HNSCC cell line using an in vitromodel. To achieve the AMF-induced hyperthermia, anin-house fabricated AMF generator was constructed. Wehypothesized that HA immobilized magneticnanoparticles (HA-DESPIONs) can selectively targetCD44 populations through CD44 binding in contrast tounmodified magnetic nanoparticles (DESPIONs).
2. Methods and Materials
2.1 Cell lineThe UT-SCC-14 cell line was obtained throughcollaboration with Dr. Reidar Grénman (University ofTurku, Finland). Clinicopathological characteristics ofUT- SCC- 14 cell line showed that it was developed fromthe second grade primary lesion of the tongue of a 25years old male patient with TNM staging as T3N1M0. Itwas maintained at low passage numbers such that itretained the phenotypic and morphologicalcharacteristics similar to the primary tumor.Overexpression of CD44 in UT-SCC-14 cells waspreviously conformed via flow cytometric analysis.18,21The doubling time of the cell line is approximately 48hours and the plating efficiency is 0.15-0.20. Cells werecultured in Dulbecco modified eagle mediumsupplemented with 10% fetal bovine serum and 2%penicillin-streptomycin, and maintained in an incubatorat 37oC with 5% CO2/95% air.
2.2 DESPIONs and HA-DESPIONs synthesisDESPIONs were processed by the formation of watersoluble nanoparticles through co-precipitation with Fe3+and Fe2+ salts (FeCl3 and FeCl2) in the presence ofdextran (16 kDa) as previously described.22HA-DESPIONs were prepared as previouslydescribed19,22 which involved the conjugation of lowmolecular weight HA polymer (31 kDa) in the presenceof 2-chloro-4,6-dimethoxy-1,3,5-triazine (CDMT) as thecoupling agent19 (Figure 1). The nanoparticles have beenthoroughly characterized by transmission electronmicroscopy, thermogravimetric analysis, elementalanalysis, dynamic light scattering, and high-resolutionmagic angle spinning NMR.22,23 The HA-DESPIONs usedin this study had hydrodynamic radius of 103 nm with acore size of around 6 nm, and a zeta potential of -13 mV,while DESPIONs were about 59.6 nm with a zetapotential of -4 mV. The thermogravimetric analysis datashowed that HA accounted for 43% weight of eachHA-DESPION.24
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Figure 1: Synthesis of HA-DESPIONs.22
Figure 2: The circuit diagram of the AMF generator.
2.3 Construction details of the AMF generatorAn AMF generator was constructed to generate AMF ofhigh strength, thus allowing for a non-contact transfer ofenergy to a load. The generator consisted of a low poweroscillator, a metal-oxide semiconductor field-effecttransistor (MOSFET) amplifier, a filter and the workresonator. The low power oscillator was aprogrammable digital circuit capable of generating avariable frequency from 74.2 kHz to 130 kHz. Theamplifier consisted of a MOSFET driver (STMicroelectronics L6384) and two high-power N-channelMOSFETs (Fairchild FQP19N20C). The output of the
amplifier stage produced a square wave. A filter blockedthe high frequency components of the square wave sothat only a sinusoidal wave could reach the workresonator. A filter consisted of a hand wound inductorL1 and a capacitor C1 (Kemet R463N333000N0M)placed in series. The work resonator was alsoconstructed from a capacitor (KemetR75QN3100AA00K) and an inductor, but instead theywere placed in parallel. The work coil L2 was a handturned copper tube. Both C1 and C2 consisted of many ofthe specified capacitors paced in parallel to achieve therequired capacitance. Placement in parallel allowed the
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whole circuit to operate at an increased power level thanany individual capacitor was capable of handling (Figure2).The test samples were placed in the center of the coil forexposure to the magnetic field. While the AMF generatorcould be operated at a lower power by setting the inputfrequency higher, it was capable and primarily used at afrequency of 74.2 kHz which produced a magnetic fieldwith strength of 10 kA/m (12.6 mT).
2.4 Bulk heating of SPIONsA series of bulk heating experiments were performed totest whether the machine was capable of generating heatvia magnetic activation of the nanoparticles. For thiskinetic study, readily available SPIONs (nanoComposix,San Diego, CA) at a concentration of 20 mg/ml wereused. The SPIONs-solution was placed in the work coiland gradually exposed to AMF for 0.5, 1.0, 1.5, 2.0, 2.5,3.0, 3.5, 4.0, 5, 6, 7, 8, 10, 15, 20, 25, and 30 minutes toestablish the minimum time required for the maximumtemperature rise. The initial and final temperature wasmeasured using a thermocouple. To verify that bulkheating was caused from the interaction specifically withferric oxide nanoparticles, four different control sampleswere studied including deionized (DI) water, 1Xphosphate buffered saline (PBS) solution, tap water andgold nanoparticles (nanoComposix, San Diego, CA) at thesame concentration as SPIONs. Based on the aboveexperiments the optimal heating time of 4 minutes wasused to determine the dose-dependence of the effectusing varying concentrations; 2.5, 5, 10, 15, and 20mg/ml of SPIONs. A volume of 400 µl was used for alltreatment samples. Each type of experiment wasperformed twice, the data were the average over the twoexperiments and plotted with the standard error of themean value.
2.5 HA-DESPION binding to CD44UT-SCC-14 cells were plated in T-25 cm2 flasks incomplete growth media at 5×105 cells/flask for 2 daysand allowed to attach overnight. Three differentexperimental groups were established: 1) control cells,2) cells treated with FITC-DESPIONs, and 3) cells treatedwith FITC-HA-DESPIONs. Next day media of control cellswere replaced with prewarmed media while group 2and 3 cells were treated with FITC-DESPIONs andFITC-HA-DESPIONs at 200 µg/ml respectively. Cellswere allowed to grow for 24 hours in an incubator at37°C with 5% CO2/95% air. After 24 hours of incubation,cells were washed four times with pre-warmed growthmedia, and trypsinized from flasks. Freshly trypsinizedcells were centrifuged at 1100 rpm for 5 minutes,washed twice with PBS solution, and resuspended at 1 ×106 cells/ml in PBS solution. Cells were, then,immediately run on a FACS Canto II flow cytometer (BDBiosciences) to measure the fluorescence (FITC)attached to the cells.
2.6 Cell culture for AMF treatmentUT-SCC-14 cells were plated in 35 mm2 dishes incomplete growth media at 2×105 cells/dish for 3 daysand allowed to grow in an incubator at 37°C with 5%CO2/95% air. Three different experimental groups wereestablished: 1) control cells, 2) cells treated withHA-DESPIONs, and 3) cells treated with DESPIONs. Eachtreatment group was replicated to compare treatmenteffects in the presence and absence of AMF. Afterovernight incubation, cells were treated withHA-DESPIONs/DESPIONs at 200 µg/ml for 24 hours.After 24 hours of incubation with nanoparticles, cellswere washed four times with pre-warmed growthmedia, and resuspended in complete growth media.Cells were then exposed to AMF-induced hyperthermiafor 30 minutes at room temperature. Cells wereincubated at 37oC for 24 hours before the analysis ofapoptotic cell death by flow cytometry.
2.7 Flow cytometry analysis after AMF treatmentTo assess the effects of treatments, cells weretrypsinized 24 hours post-treatment. Freshlytrypsinized cells were centrifuged at 1100 rpm for 5minutes, washed twice with PBS solution, andresuspended at 1 × 106 cells/ml in PBS solution. Cellswere then dual stained for CD44 (FITC) at 8 μl/ml andAnnexin V (PE) at 8 μl/ml (BD Biosciences) to evaluatethe percentage of cells undergoing apoptosis in the CD44expressing population. Each sample was stained for 1)cells only, 2) isotype-stained cells, 3) CD44-stained cells,4) Annexin-stained cells 5) CD44/Annexin dual staining.Cells were covered with aluminum foil, and incubated at4°C for 35 minutes, protected from light. After staining,cells were further washed twice with cold PBS, andresuspended in 1 ml of PBS solution. Cells were, then,immediately run on a FACS Canto II flow cytometer (BDBiosciences) to evaluate the percentage of cellsundergoing apoptosis in the CD44 expressing populationusing appropriate regions of interest.
3. Results
3.1 Bulk heating resultsThe initial studies verified that the AMF generator wascapable of activating the magnetic nanoparticles toproduce significant increases in temperature. Figure 3shows that immediately after the magnetic field isinitiated, the magnetic nanoparticles (20 mg/ml)became activated and, as a consequence, the heatingeffect was observed in the form of a rise in temperature.The minimum time of activation to achieve themaximum rise in temperature in the test scenario wasapproximately 4 minutes (Figure 3). At 4 minutes ofactivation, the temperature was recorded as 37.3°Crepresenting a 12.5°C rise from the initial roomtemperature. Further increase in time did not show asignificant change in temperature indicating that thetemperature rise plateaued when the heating of the
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magnetic nanoparticles reached a point of maximumactivation (Figure 3).
Figure 3: Generation of heat as a function of magneticfield duration; temperature changes plateau at longerAMF activation periods in 20 mg/ml of SPION solution.
Table 1: Initial (at 0 minute), and final (at 4 minutes)temperatures obtained from a series of controlsolutions.Time(minute) Temperature (oC)DI water PBS solution Gold NPs SPIONs0 24.7 24.5 24.5 24.84 24.6 24.3 24.6 37.6Table 1 shows that none of the control samples, DIwater, PBS solution and gold nanoparticles produced asignificant rise in their final temperatures in comparisonto the SPIONs.
Figure 4: The effect of SPION concentration ontemperature rise.In Figure 4, the dose-dependence studies show thatthere was a relationship between the concentration ofSPIONs and the amount of bulk heating achievedthrough the exposure to the AMF. As expected thelargest rise in the temperature of 11.6°C above the initialroom temperature (24.8°C) was observed at 4 minutesof exposure to the AMF with the highest concentrationtested (20 mg/ml). There appeared to be very littleeffect up to a concentration of 10 mg/ml after whichthere was linear correlation between SPIONsconcentration and temperature rise.
3.2 HA-DESPIONs binding test resultsAfter 24 hours of incubation, cells treated with FITC-HA-DESPIONs showed significant amount offluorescence attached to the cells (Figure 5C) comparedto the FITC-DESPIONs-treated cells (Figure 5B), andcontrol cells (Figure 5A). The mean fluorescenceintensity measured in control, FITC-DESPIONs, andFITC-HA-DESPIONs treated cells were 320±24, 427±35,and 17292±457 respectively.
Figure 5: Plots A, B, and C are the representative flow cytometric plots demonstrating amount of fluorescence (FITC)attached in control, DESPION-treated, and HA-DESPION-treated cells respectively.
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Figure 6: Figures A, B, and C are the representative flow cytometric plots demonstrating % of apoptotic CD44 celldeath detected in control cells, DESPION (200 µg/ml) treated cells, and HA-DESPION (200 µg/ml) treated cells whenthe AMF is turned on while figure D is the representative HA-DESPION treated cells when the AMF is turned off.
3.3 AMF treatment (flow cytometric analysis)
resultsFollowing exposure to AMF, non-conjugated DESPIONswere unable to induce targeted hyperthermia and hencehad no effect on CD44 cell death as they were notattached to the cells (Figure 6B), similar to control cells(Figure 6A). However, there was a significant amount ofcell death (19.3%) in CD44 expressing cells treated withHA-DESPIONs and exposed to AMF (Figure 6C). Whenthe magnetic field was turned off, HA-DESPION treatedcells had no hyperthermic effect on the CD44 population(Figure 6D), similar to all treatment groups (figures notshown here).
4. DiscussionIn HNSCCs, HA-CD44 interaction plays a significant rolein tumor progression and metastasis. As a result, HAfunctionalized nanomaterials have been investigated totarget CD44 populations and to selectively deliver drugsfor the treatment.25,26 The dextran coated nanoparticles(HA-DESPIONs) used in this study have been developedby a co-precipitation method followed by post syntheticfunctionalization of HA.22 These nanoparticles havepreviously been shown to be detectable in tumors andatherosclerotic plaques using static magnetic fields toprovide contrast for magnetic resonance imaging.19,20,22In addition, their cellular uptake and binding toCD44-overexpressed cells have also been tested. Thisindicated the importance of cell specificity and targetingin relation to hyperthermia therapy.27
As mentioned previously, another potential applicationof nanoparticles based on their ferric oxide content istheir ability to produce heat in response to AMF. For thisstudy we have generated a simple and inexpensivein-house fabricated AMF generator. The apparatus wasable to generate heat energy via magnetic activation ofmagnetic nanoparticles. However, this required a highconcentration of nanoparticles. Using a highconcentration of nanoparticles in biomedicalapplications can have serious side effects owing to theproperties of dose-dependent toxicity.28 In addition,high concentrations of magnetic nanoparticlesdominates the signal intensity of T2-weighted MRI whenthey are used as contrast enhancer.29 To address theselimitations, we used comparatively a low dose (200µg/ml) of HA-DESIPONs for the cellular study, andprovided cells sufficient (24 hours) time to interact withthe nanoparticles, and exposed cells to the AMF for themaximum time of 30 minutes according to the bulkheating kinetic study. 30 minutes was selected for thecellular studies since, generally, the internalization ofnanoparticles within cells is likely to occur in atime-dependent manner and after a certain threshold isreached the uptake is expected to plateau when cellshave reached a point of maximum saturation. Similarly,cell viability subsequent to nanoparticle uptake isexpected to be either unaffected or decrease as afunction of time.28 The cytotoxic property ofHA-DESPIONs was previously tested using a growthinhibition assay in which UT-SCC-14 cells did not show
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any cytotoxic effect with the treatment of HA-DESPIONsat the concentration of 200 µg/ml for up to 48 hours.18In one recent study, magnetically induced hyperthermiawas achieved using SPIONs in a head and neck cancerxenograft model.12 However, this was an untargetedapproach and the interactions of a targeted approachusing HA-DESPIONs directed at CD44, in the presence ofan AMF, have not been previously investigated. In termsof the in vitro studies, our results suggested thatHA-DESPIONs bind to CD44 expressing cells butrequired 24 hours of incubation to result in a significantamount of apoptotic CD44 cell death as hyperthermiatreatments performed immediately after the addition ofnanoparticle solution had no significant difference inapoptotic cell death. The data in Figure 6C clearly showthe apoptotic population emanating from theCD44-postive cells and not the CD44-negativepopulation. DESPIONs, without HA conjugation, did notshow any effects on either the CD44 positive or negativecells (Figure 6B). Our result is consistent with Kamat et
al.22 According to their study, HA receptor (CD44)expressed on the tumor cells can be recognized byHA-DESPIONs. The enzyme linked immunosorbent assay(ELISA) demonstrated the binding of HA-DESPIONs,while DESPIONs could not. Further, their cellular studiesshowed HA-DESPIONs effectively inhibited the bindingbetween the HA polymer and CD44 while the DESPIONswithout HA did not have any effect on HA-CD44interaction.The data presented in this study are encouraging butmust be considered as preliminary and the presentstudy does have limitations. First, we need to examineother HNSCC cell lines with differing expression levels ofCD44 and hyperthermic properties as described in aprevious publication.18 The studies in this report wereperformed at room temperature rather than bodytemperature due to the limitations of the currentapparatus; we are developing a system that can besituated in a 37°C incubator. Several associated studiesare ongoing. We have preliminary data that intravenousinjection of HA-DESPIONS into nude mice bearingUT-SCC-14 xenografts can be detected in a 3.0 Teslabenchtop MRI and that changes in MRI signal caused byradiation treatment correlate with observed changes inCD44 expression measured by immunohistochemistryand gene expression.30 In addition we are exploring anRF pulse sequence technique to enable activation ofhyperthermia of HA-DESPIONS in a clinical MRI.31
5. ConclusionIn this study we have demonstrated that a simple AMFgenerator was able to activate magnetic nanoparticlesand a dose-dependent heating effect was obtained. Theflow cytometry results demonstrated that HA-DESPIONswere targeted to UT-SCC-14 cells through binding to theoverexpressed surface receptor CD44 and were
activated in the presence of an AMF to generate asignificant amount of localized heat that ultimately led totumor cell death. This preliminary study needs to befurther elaborated at different time intervals andexpanded to other HNSCC cell lines but the early resultssuggest a promising strategy to specifically target CSCsin HNSCCs for treatment.
Conflict of interestThe authors declare that they have no conflicts ofinterest. The authors alone are responsible for thecontent and writing of the paper.
AcknowledgementThis work is funded by Department of RadiationOncology, Beaumont Health System, and OaklandUniversity Provost Graduate Student Research Award.
References1. Vermorken JB, Remenar E, van Herpen C, et al.Cisplatin, fluorouracil, and docetaxel inunresectable head and neck cancer. N Engl JMed. 2007;357(17):1695-704.2. Pignon JP, le Maître A, Maillard E, et al.Meta-analysis of chemotherapy in head andneck cancer (MACH-NC): an update on 93randomised trials and 17,346 patients.Radiother Oncol. 2009;92(1):4-14.3. Reya T, Morrison SJ, Clarke MF, Weissman IL.Stem cells, cancer, and cancer stem cells.Nature. 2001;414(6859):105-11.4. Prince ME, Sivanandan R, Kaczorowski A, et al.Identification of a subpopulation of cells withcancer stem cell properties in head and necksquamous cell carcinoma. Proc Natl Acad Sci US A. 2007;104(3):973-8.5. Wang SJ, Wong G, de Heer AM, et al. CD44Variant isoforms in head and neck squamouscell carcinoma progression. Laryngoscope.2009;119(8):1518-30.6. Toole BP, Slomiany MG. Hyaluronan, CD44 andEmmprin: partners in cancer cellchemoresistance. Drug Resist Updat.2008;11(3):110-21.7. Laurent TC, Laurent UB, Fraser JR. Thestructure and function of hyaluronan: Anoverview. Immunol Cell Biol. 1996;74(2):A1-7.8. Bartolazzi A, Peach R, Aruffo A, Stamenkovic I.Interaction betwenn CD44 and hyaluronate isdirectly implicated in the regulation oftumor-development. J Exp Med. 1994;180(1):53-66.9. Liu W, Frank JA. Detection and quantification ofmagnetically labeled cells by cellular MRI. Eur JRadiol. 2009;70(2):258-64.10. Dixon WT, Blezek DJ, Lowery LA, et al.Estimating amounts of iron oxide from gradient
8 Thapa et al.: Nanoparticles causes apoptosis of CD44 expressing HNSCC cells International Journal of Cancer Therapy and Oncology
www.ijcto.org
© Thapa et al. ISSN 2330-4049
echo images. Magn Reson Med. 2009;61(5):1132-6.11. Ang KK, Andratschke NH, Milas L. Epidermalgrowth factor receptor and response ofhead-and-neck carcinoma to therapy. Int JRadiat Oncol Biol Phys. 2004;58(3):959-65.12. Zhao Q, Wang LN, Cheng R, et al. Magneticnanoparticle-based hyperthermia for head &neck cancer in mouse models. Theranostics.2012;2(1):113-21.13. Drake P, Cho H-J, Shih P-S, et al. Gd-dopediron-oxide nanoparticles for tumour therapyvia magnetic field hyperthermia. J Mater Chem.2007;17(46):4914-8.14. Smolkova IS, Kazantseva NE, Babayan V, et al.Alternating magnetic field energy absorption inthe dispersion of iron oxide nanoparticles in aviscous medium. J Magn Magn Mater.2015;374:508-15.15. Thomas LA, Dekker L, Kallumadil M, et al.Carboxylic acid-stabilised iron oxidenanoparticles for use in magnetichyperthermia. J Mater Chem. 2009;19(36):6529-35.16. Muller S. Magnetic fluid hyperthermia therapyfor malignant brain tumors-an ethicaldiscussion. Nanomedicine. 2009;5(4):387-93.17. Provenzale JM, Silva GA. Uses of Nanoparticlesfor Central Nervous System Imaging andTherapy. AJNR Am J Neuroradiol. 2009;30(7):1293-301.18. Thapa R, Galoforo S, Kandel SM, et al.Radiosensitizing and hyperthermic propertiesof hyaluronan conjugated, dextran-coated ferricoxide nanoparticles: Implications for cancerstem cell therapy. J Nanomater. 2015;2015:840594.19. El-Dakdouki MH, Zhu DC, El-Boubbou K, et al.Development of multifunctionalhyaluronan-coated nanoparticles for imagingand drug delivery to cancer cells.Biomacromolecules. 2012;13(4):1144-51.20. El-Dakdouki MH, El-Boubbou K, Kamat M, et al.CD44 Targeting magnetic glyconanoparticlesfor atherosclerotic plaque imaging. Pharm Res.2014;31(6):1426-37.21. Wilson GD, Marples B, Galoforo S, et al. Isolationand genomic characterization of stem cells in
head and neck cancer. Head Neck. 2013;35(11):1573-82.22. Kamat M, El-Boubbou K, Zhu DC, et al.Hyaluronic acid immobilized magneticnanoparticles for active targeting and imagingof macrophages. Bioconjug Chem. 2010;21(11):2128-35.23. El-Boubbou K, Zhu DC, Vasileiou C, et al.Magnetic glyco-nanoparticles: a tool to detect,differentiate, and unlock the glyco-codes ofcancer via magnetic resonance imaging. J AmChem Soc. 2010;132(12):4490-9.24. El-Dakdouki MH, El-Boubbou K, Zhu DC, HuangX. A simple method for the synthesis ofhyaluronic acid coated magnetic nanoparticlesfor highly efficient cell labelling and in vivoimaging. Rsc Adv. 2011;1(8):1449-52.25. Thapa R, Wilson GD. Head and neck cancer:Current treatment options and associatedchallenges. Sch J App Med Sci. 2016;4(2D):590-600.26. Thapa R, Wilson GD. The importance of CD44 asa stem cell biomarker and therapeutic target incancer. Stem Cells Int. 2016;2016:2087204.27. Thomas RG, Moon MJ, Lee H, et al. Hyaluronicacid conjugated superparamagnetic iron oxidenanoparticle for cancer diagnosis andhyperthermia therapy. Carbohydr Polym.2015;131:439-46.28. Singh N, Jenkins GJS, Asadi R, Doak SH. Potentialtoxicity of superparamagnetic iron oxidenanoparticles (SPION). Nano Rev. 2010;1.29. Wabler M, Zhu W, Hedayati M, et al. Magneticresonance imaging contrast of iron oxidenanoparticles developed for hyperthermia isdominated by iron content. Int J Hyperthermia.2014;30(3):192-200.30. Wilson GD, Thibodeau BJ, Fortier LE, et al.Cancer Stem Cell Signaling during Repopulationin Head and Neck Cancer. Stem Cells Int.2016;2016:1894782.31. Yee S, Ionascu D, Thapa R, Wilson GD. Anexploratory RF pulse sequence technique usedto induce differential heating in tissuescontaining iron oxide nanoparticles for apossible hyperthermic adjuvant effect toradiotherapy. Med Phys. 2014;41:356.
